Cargando…

Major clinical research advances in gynecologic cancer in 2012

Ten topics were chosen among major clinical research achievements in gynecologic oncology in 2012. For ovarian cancer, comprehensive review of the history of bevacizumab studies was followed by poly adenosine diphosphate [ADP]-ribose polymerase (PARP) inhibitors and other molecular targeted agents s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suh, Dong Hoon, Kim, Jae-Weon, Kim, Kidong, Kim, Hak Jae, Lee, Kyung-Hun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549510/ https://www.ncbi.nlm.nih.gov/pubmed/23346316 http://dx.doi.org/10.3802/jgo.2013.24.1.66

Ejemplares similares

Major clinical research advances in gynecologic cancer in 2014
por: Suh, Dong Hoon, et al.
Publicado: (2015)

Major clinical research advances in gynecologic cancer in 2016: 10-year special edition
por: Suh, Dong Hoon, et al.
Publicado: (2017)

Major clinical research advances in gynecologic cancer in 2011
por: Suh, Dong Hoon, et al.
Publicado: (2012)

Major clinical research advances in gynecologic cancer in 2015
por: Suh, Dong Hoon, et al.
Publicado: (2016)

Major clinical research advances in gynecologic cancer in 2013
por: Suh, Dong Hoon, et al.
Publicado: (2014)

Major clinical research advances in gynecologic cancer in 2017
por: Suh, Dong Hoon, et al.
Publicado: (2018)

Major clinical research advances in gynecologic cancer in 2018
por: Kim, Miseon, et al.
Publicado: (2019)

Major clinical research advances in gynecologic cancer in 2019
por: Kim, Miseon, et al.
Publicado: (2020)

Major clinical research advances in gynecologic cancer in 2020
por: Lee, Yoo-Young, et al.
Publicado: (2021)

Major clinical research advances in gynecologic cancer in 2021
por: Park, Jeong-Yeol, et al.
Publicado: (2022)

Factors affecting pain during outpatient clinic based surgical procedures in gynecologic oncology
por: Kim, Kidong, et al.
Publicado: (2018)

Maximum daily dose of G-CSF is critical for preventing recurrence of febrile neutropenia in patients with gynecologic cancer: A case–control study
por: Kim, Nam Kyeong, et al.
Publicado: (2022)

Nomogram predicting risk of lymphocele in gynecologic cancer patients undergoing pelvic lymph node dissection
por: Yoo, Baraem, et al.
Publicado: (2017)

Efficacy of the multidisciplinary tumor board conference in gynecologic oncology: A prospective study
por: Lee, Banghyun, et al.
Publicado: (2017)

Controversies in the management of endometrial cancer: a survey of the Korean Gynecologic Oncology Group
por: Lee, Jung-Yun, et al.
Publicado: (2015)

Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in locally advanced cervical cancer
por: Lee, Jung-Yun, et al.
Publicado: (2015)

The association between diarrhea and serum cytokines in patients with gynecologic cancer treated with surgery and pelvic chemoradiotherapy
por: Eom, Keun-Yong, et al.
Publicado: (2021)

The 34th Annual Meeting of the Korean Society of Gynecologic Oncology 2019: meeting report
por: Yim, Ga Won, et al.
Publicado: (2019)

Feasibility of extended cycles of neoadjuvant chemotherapy in patients with advanced ovarian cancer in terms of prognosis and surgical outcomes
por: Kim, Nam Kyeong, et al.
Publicado: (2023)

Minimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery position statement
por: Kim, Miseon, et al.
Publicado: (2019)

Impact of Underweight after Treatment on Prognosis of Advanced-Stage Ovarian Cancer
por: Kim, Se Ik, et al.
Publicado: (2014)

Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3
por: Lee, Jung-Yun, et al.
Publicado: (2023)

The Journal of Gynecologic Oncology and the Asian Society of Gynecologic Oncology: the history, the present and the future
por: Chang, Ki-Hong, et al.
Publicado: (2012)

Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition
por: Lee, Jae Kwan, et al.
Publicado: (2013)

Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines
por: Cho, Hyun-Woong, et al.
Publicado: (2021)

Clinical Implication of PD-L1 Expression in Patients with Endometrial Cancer
por: Kim, Yeorae, et al.
Publicado: (2023)

Clinical guideline for 9-valent HPV vaccine: Korean Society of Gynecologic Oncology Guideline
por: Min, Kyung-Jin, et al.
Publicado: (2019)

Clinical evaluation of a droplet digital PCR assay for detecting POLE mutations and molecular classification of endometrial cancer
por: Kim, Gilhyang, et al.
Publicado: (2021)

Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO)
por: Choi, Min Chul, et al.
Publicado: (2016)

Role of preoperative magnetic resonance imaging and histological assessment in identifying patients with a low risk of endometrial cancer: a Korean Gynecologic Oncology Group ancillary study
por: Lee, Jung-Yun, et al.
Publicado: (2017)

Machine Learning Models to Predict Survival Outcomes According to the Surgical Approach of Primary Radical Hysterectomy in Patients with Early Cervical Cancer
por: Kim, Se Ik, et al.
Publicado: (2021)

Clinical implications of neoadjuvant chemotherapy in advanced endometrial cancer: a multi-center retrospective cohort study
por: Lim, Hyunji, et al.
Publicado: (2022)

After the Laparoscopic Approach to Cervical Cancer (LACC) trial: Korean Society of Gynecologic Oncology (KSGO) survey
por: Kim, Miseon, et al.
Publicado: (2019)

Serum Human Epididymis Protein 4 as a Prognostic Marker in Cervical Cancer
por: Hwang, Woo Yeon, et al.
Publicado: (2022)

Phase II Study of Consolidation Chemotherapy after Adjuvant or Primary Concurrent Chemoradiation Using Paclitaxel and Carboplatin to Treat High-Risk Early-Stage or Locally Advanced Cervical Cancer
por: Kim, Hee Seung, et al.
Publicado: (2012)

Role of limonin in anticancer effects of Evodia rutaecarpa on ovarian cancer cells
por: Bae, Jae Ryul, et al.
Publicado: (2020)

Clinical features that affect the number of pelvic lymph nodes harvested in patients with cervical cancer stage IB1 to IIA2
por: Choi, Yae Ji, et al.
Publicado: (2021)

Matched-Case Comparisons in a Single Institution to Determine Critical Points for Inexperienced Surgeons’ Successful Performances of Laparoscopic Radical Hysterectomy versus Abdominal Radical Hysterectomy in Stage IA2-IIA Cervical Cancer
por: Suh, Dong Hoon, et al.
Publicado: (2015)

Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cycles
por: Kim, Se Ik, et al.
Publicado: (2020)

Association of nursing-documented ambulation with length of stay following total laparoscopic hysterectomy for benign gynecologic disease
por: Kim, Kidong, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_20o58hhufsdn3sncr92crcau60